Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA
|
|
- Allen Leonard
- 5 years ago
- Views:
Transcription
1 Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA Dept. Chem. & Biochem. Kennesaw State University, Kennesaw, GA, Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA
2 Background Acetylcholinesterase Acetylcholinesterase(AChE) is a multifunctional enzyme found in cholinergic system Function: Terminates nerve impulses of acetylcholine origin Promotes production of β-amyloid protein Associated with pathogenesis of Alzheimer's Disease (AD) Impairs cholinergic system Reduced amount of acetylcholine Promote formation of Plaques Insoluble β-amyloid protein com
3 Alzheimer's Disease Age related chronic neurodegenerative dementia Affects 20 million people worldwide Develops in stages Early to advanced Available drugs only able to treat certain stage only Drugs have associated side effects Need for therapeuticti measures with ability to treatt all stages of AD with less or no side effects
4 Structure Model structure of Torpedo californica AChE (TcAChE) Peripheral Anionic Site (PAS) Trp 279 Catalytic Anionic Site (CAS) Trp 84 Lining of aromatic residues 54 X-ray structures with bound ligands Xu. et al. Induced fit or preexisting equilibrium dynamics? 2008,17:601-5
5 Inhibition Binding activity at CAS well understood while that of PAS still elusive PAS site associated with formation of plaques Treatment at all stages of AD ineffective due to drug inhibition only at the CAS site Inhibition at both sites is key to effective treatment Hence using available generated dual-inhibitors of TcAChE will generate more effective inhibitors
6 Aims of this Study Develop a molecule-derived pharmacophore model (MOE) using known PAS and CAS inhibitors Use pharmacophore p model to identify structurally diverse active compounds by virtual screening
7 Strategy (LBDD) Start (SBDD) TcAChE Training set Top 5 Hits Pharmacophore Model Development Experimental testing (TBD) Pharmacophore Model Validation Lipinski`s Rule of Five Criteria 3D Database screening Top 25 Hits
8 ACTIVE DUAL INHIBITORS
9 Training set
10 Pharmacophore Query Generation Training set: 6 compounds Features defined: Hydrogen-bond acceptor (ACC) Hydrogen-bond donor (DON) Hydrophobic (HYD) Aromatic (ARO) Conformer generation 4 kcal/mol l
11 Queries 3 Queries generated: Query Molecule(s) Tolerance Radius Features a ReF_Vol Donepezil 1.74 HYD ARO 3Vols Ref_No _Vol Donepezil 1.4 HYD ARO Consensus All training set molecules 1.4 HYD ACC DON ARO. a ACC,hydrogen-bond acceptor; DON, hydrogen-bond donor; HYD, hydrophobic, ARO, ring aromatic, Vols, excluded volumes
12 Reference Queries Reference query without excluded volumes generated using Donepezil the meshed spheres represent pharmacophoric features. TRP 279 TRP84 PHE330 Reference query with excluded volumes generated using Donepezil. The meshed spheres are the pharmacophore features (ARO, HYD). Solid spheres (red, blue and cyan colored) represents excluded volumes.
13 Consensus Query Bis5 tacrine Bis10 Hupyridone Aminoquinoline28 Bw284c51 Decamethonium Donepezil Fig 4: Flexible aligned training set showing defined features scheme used to generate the query Consensus query generated from flexible aligned training set. The spheres are the pharmacophore features (Aro, Acc, Hyd, Don) that novel pharmacophores were aligned. Molecules matching those features satisfied the query and were therefore hits
14 Validation TEST SET: 8 active compounds All 8 molecules satisfied the three queries
15 Database Preparation & Search (MOE) ZINC ~ 2.8 M total number of compounds ~ 900,000 lead-like compounds 27,491 compounds screened Created conformation database: 703,313 compounds
16 Database Search Results and Sorting Query Ref:Vol Ref:No Vol Consensus Number of hits Sort top Common hits 68 Selection based on lowest rmsd value ( Å) 25
17 Sorted Hits (cont.) Consensus compounds generated by all queries and their respective RMSD values.
18 Sorted Hits (2D Structures)
19 Virtual Screening Flexible Docking with Molegro Virtal Docker Full side-chain flexibility Cavity detection dynamically used during the docking process Improved scoring function hydrogen bond directionality taken into account Table 1: Accuracy of selected docking programs. A binding mode is regarded as correctly identified if the RMSD (to the native co-crystallized ligand) is less than 2.0Å. The dataset consists of the 77 complexes *Thomsen R, Christensen M H, J Med Chem 2006; 49:
20 Docking Results Top 5 ZINC compounds docked in the binding sites of TcAChE
21 Docking Results (cont.) E2020 (Donepezil) and ZINC from different view points. Visual of how well the zinc compounds aligned in the binding site similar to Donepezil
22 Conclusion Using a combination of ligand based and structure based drug design approaches we have identified structurally diverse dual inhibitor candidates for TcAChE Future Work Virtually screen the remaining lead-like like compounds of the ZINC database Prioritize hits for experimental testing (i.e. binding free energy; types of interactions in the active site)
23 Acknowledgements Dr Gabriela Mustata Dr Jeffry Madura BBSI Program NIH & NSF
24 References 1. Lin A. Overview of pharmacophore p Application in MOE. Chemica Computing group. /ph4.htmhtm 2. Irwin and Stoichet. J. Chem. (2005); 45(1): Info. 3. Molegro Virtual Docker. molegro.com 4. Xu Model. Xu. et al. induced fit or preexisting equilibrium dynamics? Protein Science (2008), 17: 601-5
ing equilibrium i Dynamics? simulations on AchE and Implications for Edwin Kamau Protein Science (2008). 17: /29/08
Induced-fit d or Pre-existin ing equilibrium i Dynamics? Lessons from Protein Crystallography yand MD simulations on AchE and Implications for Structure-based Drug De esign Xu Y. et al. Protein Science
More informationStructural biology and drug design: An overview
Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved
More informationDOCKING TUTORIAL. A. The docking Workflow
2 nd Strasbourg Summer School on Chemoinformatics VVF Obernai, France, 20-24 June 2010 E. Kellenberger DOCKING TUTORIAL A. The docking Workflow 1. Ligand preparation It consists in the standardization
More informationUsing Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017
Using Phase for Pharmacophore Modelling 5th European Life Science Bootcamp March, 2017 Phase: Our Pharmacohore generation tool Significant improvements to Phase methods in 2016 New highly interactive interface
More informationCreating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner
Table of Contents Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Features
More informationTargeting protein-protein interactions: A hot topic in drug discovery
Michal Kamenicky; Maria Bräuer; Katrin Volk; Kamil Ödner; Christian Klein; Norbert Müller Targeting protein-protein interactions: A hot topic in drug discovery 104 Biomedizin Innovativ patientinnenfokussierte,
More informationPerforming a Pharmacophore Search using CSD-CrossMiner
Table of Contents Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Searching with a Pharmacophore... 4 Performing a Pharmacophore Search using CSD-CrossMiner Version 2.0
More informationReceptor Based Drug Design (1)
Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals
More informationIntroduction to Chemoinformatics and Drug Discovery
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013 The Chemical Space There are atoms and space. Everything else is opinion. Democritus (ca.
More informationDr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre
Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput
More informationGoals. Structural Analysis of the EGR Family of Transcription Factors: Templates for Predicting Protein DNA Interactions
Structural Analysis of the EGR Family of Transcription Factors: Templates for Predicting Protein DNA Interactions Jamie Duke 1,2 and Carlos Camacho 3 1 Bioengineering and Bioinformatics Summer Institute,
More informationMedicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design
Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Computer Aided Drug Design - Introduction Development
More informationLigand Scout Tutorials
Ligand Scout Tutorials Step : Creating a pharmacophore from a protein-ligand complex. Type ke6 in the upper right area of the screen and press the button Download *+. The protein will be downloaded and
More informationProgress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery
21 th /June/2018@CUGM Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery Kaz Ikeda, Ph.D. Keio University Self Introduction Keio University, Tokyo, Japan (Established
More informationDocking. GBCB 5874: Problem Solving in GBCB
Docking Benzamidine Docking to Trypsin Relationship to Drug Design Ligand-based design QSAR Pharmacophore modeling Can be done without 3-D structure of protein Receptor/Structure-based design Molecular
More informationVirtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME
Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Iván Solt Solutions for Cheminformatics Drug Discovery Strategies for known targets High-Throughput Screening (HTS) Cells
More informationJournal of Molecular Graphics and Modelling
Journal of Molecular Graphics and Modelling 38 (2012) 194 210 Contents lists available at SciVerse ScienceDirect Journal of Molecular Graphics and Modelling j ourna l ho me page: www.elsevier.com/locate/jmgm
More informationDifferent conformations of the drugs within the virtual library of FDA approved drugs will be generated.
Chapter 3 Molecular Modeling 3.1. Introduction In this study pharmacophore models will be created to screen a virtual library of FDA approved drugs for compounds that may inhibit MA-A and MA-B. The virtual
More informationRetrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a
Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:
More informationComputational chemical biology to address non-traditional drug targets. John Karanicolas
Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints
More informationLigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer
LigandScout Automated Structure-Based Pharmacophore Model Generation Gerhard Wolber* and Thierry Langer * E-Mail: wolber@inteligand.com Pharmacophores from LigandScout Pharmacophores & the Protein Data
More informationCHAPTER-2. Drug discovery is a comprehensive approach wherein several disciplines
36 CAPTER-2 Molecular Modeling Analog Based Studies Drug discovery is a comprehensive approach wherein several disciplines are used to design or discover the drugs. The R&D expenditure incurred to bring
More informationIdentifying Interaction Hot Spots with SuperStar
Identifying Interaction Hot Spots with SuperStar Version 1.0 November 2017 Table of Contents Identifying Interaction Hot Spots with SuperStar... 2 Case Study... 3 Introduction... 3 Generate SuperStar Maps
More informationBiologically Relevant Molecular Comparisons. Mark Mackey
Biologically Relevant Molecular Comparisons Mark Mackey Agenda > Cresset Technology > Cresset Products > FieldStere > FieldScreen > FieldAlign > FieldTemplater > Cresset and Knime About Cresset > Specialist
More informationElectronic Supplementary Information. A biologically relevant fluorescent probe to assess the binding of ceramide to the CERT transfer protein
This journal is The Royal Society of Chemistry 20 Electronic Supplementary Information A biologically relevant fluorescent probe to assess the binding of ceramide to the CERT transfer protein Stéphanie
More informationIntroduction. OntoChem
Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads
More informationFragment Hotspot Maps: A CSD-derived Method for Hotspot identification
Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification Chris Radoux www.ccdc.cam.ac.uk radoux@ccdc.cam.ac.uk 1 Introduction Hotspots Strongly attractive to organic molecules Organic molecules
More informationComputational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007
Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based
More informationCHAPTER 3. Pharmacophore modelling studies:
CHAPTER 3 Pharmacophore modelling studies: 3.1 Introduction: According to Langer & Wolber (2004), the key goal of computer-aided molecular design methods in medicinal chemistry is to reduce the time and
More informationPlan. Day 2: Exercise on MHC molecules.
Plan Day 1: What is Chemoinformatics and Drug Design? Methods and Algorithms used in Chemoinformatics including SVM. Cross validation and sequence encoding Example and exercise with herg potassium channel:
More informationBuilding a Homology Model of the Transmembrane Domain of the Human Glycine α-1 Receptor
Building a Homology Model of the Transmembrane Domain of the Human Glycine α-1 Receptor Presented by Stephanie Lee Research Mentor: Dr. Rob Coalson Glycine Alpha 1 Receptor (GlyRa1) Member of the superfamily
More informationAdvanced Medicinal Chemistry SLIDES B
Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability
More informationLaboratory Exercises. Molecular Docking of Enzyme Inhibitors* hs A COMPUTATIONAL TOOL FOR STRUCTURE-BASED DRUG DESIGN
Q 2010 by The International Union of Biochemistry and Molecular Biology BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION Vol. 38, No. 4, pp. 261 265, 2010 Laboratory Exercises Molecular Docking of Enzyme Inhibitors*
More informationThe Schrödinger KNIME extensions
The Schrödinger KNIME extensions Computational Chemistry and Cheminformatics in a workflow environment Jean-Christophe Mozziconacci Volker Eyrich Topics What are the Schrödinger extensions? Workflow application
More informationViewing and Analyzing Proteins, Ligands and their Complexes 2
2 Viewing and Analyzing Proteins, Ligands and their Complexes 2 Overview Viewing the accessible surface Analyzing the properties of proteins containing thousands of atoms is best accomplished by representing
More information11. IN SILICO DOCKING ANALYSIS
11. IN SILICO DOCKING ANALYSIS 11.1 Molecular docking studies of major active constituents of ethanolic extract of GP The major active constituents are identified from the ethanolic extract of Glycosmis
More informationDevelopment of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining
Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining Samer Haidar 1, Zouhair Bouaziz 2, Christelle Marminon 2, Tiomo Laitinen 3, Anti Poso
More informationDispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses
Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,
More informationStructure-based maximal affinity model predicts small-molecule druggability
Structure-based maximal affinity model predicts small-molecule druggability Alan Cheng alan.cheng@amgen.com IMA Workshop (Jan 17, 2008) Druggability prediction Introduction Affinity model Some results
More informationPlan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.
Plan Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics. Exercise: Example and exercise with herg potassium channel: Use of
More informationData Quality Issues That Can Impact Drug Discovery
Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,
More informationUsing Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface
Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites Introduction J. Andrew Surface Hampden-Sydney College / Virginia Commonwealth University In the past several decades
More informationThe PhilOEsophy. There are only two fundamental molecular descriptors
The PhilOEsophy There are only two fundamental molecular descriptors Where can we use shape? Virtual screening More effective than 2D Lead-hopping Shape analogues are not graph analogues Molecular alignment
More informationPing-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.
Pharmacophore-based Drug design Ping-Chiang Lyu Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University 96/08/07 Outline Part I: Analysis The analytical
More informationVirtual screening in drug discovery
Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery
More informationUsing AutoDock for Virtual Screening
Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying
More informationSchrodinger ebootcamp #3, Summer EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist
Schrodinger ebootcamp #3, Summer 2016 EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist Numerous applications Generating conformations MM Agenda http://www.schrodinger.com/macromodel
More informationLigand-receptor interactions
University of Silesia, Katowice, Poland 11 22 March 2013 Ligand-receptor interactions Dr. Pavel Polishchuk A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine Odessa, Ukraine
More informationOther Cells. Hormones. Viruses. Toxins. Cell. Bacteria
Other Cells Hormones Viruses Toxins Cell Bacteria ΔH < 0 reaction is exothermic, tells us nothing about the spontaneity of the reaction Δ H > 0 reaction is endothermic, tells us nothing about the spontaneity
More informationMM-PBSA Validation Study. Trent E. Balius Department of Applied Mathematics and Statistics AMS
MM-PBSA Validation Study Trent. Balius Department of Applied Mathematics and Statistics AMS 535 11-26-2008 Overview MM-PBSA Introduction MD ensembles one snap-shots relaxed structures nrichment Computational
More informationChemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller
Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics
More informationScoring functions for of protein-ligand docking: New routes towards old goals
3nd Strasbourg Summer School on Chemoinformatics Strasbourg, June 25-29, 2012 Scoring functions for of protein-ligand docking: New routes towards old goals Christoph Sotriffer Institute of Pharmacy and
More informationHydrogen Bonding & Molecular Design Peter
Hydrogen Bonding & Molecular Design Peter Kenny(pwk.pub.2008@gmail.com) Hydrogen Bonding in Drug Discovery & Development Interactions between drug and water molecules (Solubility, distribution, permeability,
More informationBinding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces
J. Chem. Inf. Model. 2007, 47, 2303-2315 2303 Binding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces Shijun Zhong and Alexander D. MacKerell, Jr.* Computer-Aided Drug Design
More informationVirtual Screening: How Are We Doing?
Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global
More informationSupplementary information for cloud computing approaches for prediction of ligand binding poses and pathways
Supplementary information for cloud computing approaches for prediction of ligand binding poses and pathways Morgan Lawrenz 1, Diwakar Shukla 1,2 & Vijay S. Pande 1,2 1 Department of Chemistry, Stanford
More informationSolutions and Non-Covalent Binding Forces
Chapter 3 Solutions and Non-Covalent Binding Forces 3.1 Solvent and solution properties Molecules stick together using the following forces: dipole-dipole, dipole-induced dipole, hydrogen bond, van der
More informationA Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors
A Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors Rajarshi Guha, Debojyoti Dutta, Ting Chen and David J. Wild School of Informatics Indiana University and Dept.
More informationHigh Throughput In-Silico Screening Against Flexible Protein Receptors
John von Neumann Institute for Computing High Throughput In-Silico Screening Against Flexible Protein Receptors H. Sánchez, B. Fischer, H. Merlitz, W. Wenzel published in From Computational Biophysics
More informationSupplementary Information
Supplementary Information Resveratrol Serves as a Protein-Substrate Interaction Stabilizer in Human SIRT1 Activation Xuben Hou,, David Rooklin, Hao Fang *,,, Yingkai Zhang Department of Medicinal Chemistry
More informationUsing Self-Organizing maps to accelerate similarity search
YOU LOGO Using Self-Organizing maps to accelerate similarity search Fanny Bonachera, Gilles Marcou, Natalia Kireeva, Alexandre Varnek, Dragos Horvath Laboratoire d Infochimie, UM 7177. 1, rue Blaise Pascal,
More informationSequence Based Bioinformatics
Structural and Functional Analysis of Inosine Monophosphate Dehydrogenase using Sequence-Based Bioinformatics Barry Sexton 1,2 and Troy Wymore 3 1 Bioengineering and Bioinformatics Summer Institute, Department
More informationHit Finding and Optimization Using BLAZE & FORGE
Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology
More informationPrediction and refinement of NMR structures from sparse experimental data
Prediction and refinement of NMR structures from sparse experimental data Jeff Skolnick Director Center for the Study of Systems Biology School of Biology Georgia Institute of Technology Overview of talk
More informationSimilarity Search. Uwe Koch
Similarity Search Uwe Koch Similarity Search The similar property principle: strurally similar molecules tend to have similar properties. However, structure property discontinuities occur frequently. Relevance
More informationIn silico pharmacology for drug discovery
In silico pharmacology for drug discovery In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of
More informationJournal of Pharmacology and Experimental Therapy-JPET#172536
A NEW NON-PEPTIDIC INHIBITOR OF THE 14-3-3 DOCKING SITE INDUCES APOPTOTIC CELL DEATH IN CHRONIC MYELOID LEUKEMIA SENSITIVE OR RESISTANT TO IMATINIB Manuela Mancini, Valentina Corradi, Sara Petta, Enza
More informationOctober 6 University Faculty of pharmacy Computer Aided Drug Design Unit
October 6 University Faculty of pharmacy Computer Aided Drug Design Unit CADD@O6U.edu.eg CADD Computer-Aided Drug Design Unit The development of new drugs is no longer a process of trial and error or strokes
More informationGC and CELPP: Workflows and Insights
GC and CELPP: Workflows and Insights Xianjin Xu, Zhiwei Ma, Rui Duan, Xiaoqin Zou Dalton Cardiovascular Research Center, Department of Physics and Astronomy, Department of Biochemistry, & Informatics Institute
More informationNature Structural and Molecular Biology: doi: /nsmb.2938
Supplementary Figure 1 Characterization of designed leucine-rich-repeat proteins. (a) Water-mediate hydrogen-bond network is frequently visible in the convex region of LRR crystal structures. Examples
More informationComputational analysis of the activity of pongachalcone I against highly resistant bacteria Pseudomonas putida
Computational analysis of the activity of pongachalcone I against highly resistant bacteria Pseudomonas putida Satya B. Paul 1, Sudip Choudhury 2,* 1 Department of Chemistry, Assam University, Silchar,
More informationMolecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design
Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design Sundarapandian Thangapandian, Shalini John, Mahreen Arooj, Keun Woo Lee* Division of Applied
More informationWhat is Protein-Ligand Docking?
MOLECULAR DOCKING Definition: What is Protein-Ligand Docking? Computationally predict the structures of protein-ligand complexes from their conformations and orientations. The orientation that maximizes
More informationInternational Journal of Integrative Biology A journal for biology beyond borders ISSN
Report International Journal of Integrative Biology A journal for biology beyond borders ISSN 0973-8363 against acetylcholine esterase associated with Alzheimer s disease Sriramamurthy Boppana 1, Nataraj
More informationStructure based drug design and LIE models for GPCRs
Structure based drug design and LIE models for GPCRs Peter Kolb kolb@docking.org Shoichet Lab ACS 237 th National Meeting, March 24, 2009 p.1/26 [Acknowledgements] Brian Shoichet John Irwin Mike Keiser
More informationStructure Investigation of Fam20C, a Golgi Casein Kinase
Structure Investigation of Fam20C, a Golgi Casein Kinase Sharon Grubner National Taiwan University, Dr. Jung-Hsin Lin University of California San Diego, Dr. Rommie Amaro Abstract This research project
More information*Corresponding Author *K. F.: *T. H.:
Theoretical Analysis of Activity Cliffs among Benzofuranone Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach
More informationProtein Structure Prediction and Protein-Ligand Docking
Protein Structure Prediction and Protein-Ligand Docking Björn Wallner bjornw@ifm.liu.se Jan. 24, 2014 Todays topics Protein Folding Intro Protein structure prediction How can we predict the structure of
More information5.1. Hardwares, Softwares and Web server used in Molecular modeling
5. EXPERIMENTAL The tools, techniques and procedures/methods used for carrying out research work reported in this thesis have been described as follows: 5.1. Hardwares, Softwares and Web server used in
More informationGyörgy M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences
Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules
More informationKd = koff/kon = [R][L]/[RL]
Taller de docking y cribado virtual: Uso de herramientas computacionales en el diseño de fármacos Docking program GLIDE El programa de docking GLIDE Sonsoles Martín-Santamaría Shrödinger is a scientific
More informationType II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G2019S.
Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G219S. Min Liu@&*, Samantha A. Bender%*, Gregory D Cuny@, Woody Sherman, Marcie Glicksman@ Soumya
More informationGenerating Small Molecule Conformations from Structural Data
Generating Small Molecule Conformations from Structural Data Jason Cole cole@ccdc.cam.ac.uk Cambridge Crystallographic Data Centre 1 The Cambridge Crystallographic Data Centre About us A not-for-profit,
More informationDesign and Synthesis of the Comprehensive Fragment Library
YOUR INNOVATIVE CHEMISTRY PARTNER IN DRUG DISCOVERY Design and Synthesis of the Comprehensive Fragment Library A 3D Enabled Library for Medicinal Chemistry Discovery Warren S Wade 1, Kuei-Lin Chang 1,
More informationDrug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters
Drug Design 2 Oliver Kohlbacher Winter 2009/2010 11. QSAR Part 4: Selected Chapters Abt. Simulation biologischer Systeme WSI/ZBIT, Eberhard-Karls-Universität Tübingen Overview GRIND GRid-INDependent Descriptors
More informationProtein Structure. W. M. Grogan, Ph.D. OBJECTIVES
Protein Structure W. M. Grogan, Ph.D. OBJECTIVES 1. Describe the structure and characteristic properties of typical proteins. 2. List and describe the four levels of structure found in proteins. 3. Relate
More informationICM-Chemist-Pro How-To Guide. Version 3.6-1h Last Updated 12/29/2009
ICM-Chemist-Pro How-To Guide Version 3.6-1h Last Updated 12/29/2009 ICM-Chemist-Pro ICM 3D LIGAND EDITOR: SETUP 1. Read in a ligand molecule or PDB file. How to setup the ligand in the ICM 3D Ligand Editor.
More informationTowards Physics-based Models for ADME/Tox. Tyler Day
Towards Physics-based Models for ADME/Tox Tyler Day Overview Motivation Application: P450 Site of Metabolism Application: Membrane Permeability Future Directions and Applications Motivation Advantages
More informationBUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions
BUDE A General Purpose Molecular Docking Program Using OpenCL Richard B Sessions 1 The molecular docking problem receptor ligand Proteins typically O(1000) atoms Ligands typically O(100) atoms predicted
More informationEnhancing Specificity in the Janus Kinases: A Study on the Thienopyridine. JAK2 Selective Mechanism Combined Molecular Dynamics Simulation
Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2015 Supporting Information Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine
More informationJoana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP)
Joana Pereira Lamzin Group EMBL Hamburg, Germany Small molecules How to identify and build them (with ARP/wARP) The task at hand To find ligand density and build it! Fitting a ligand We have: electron
More informationSupporting Information
Supporting Information Ottmann et al. 10.1073/pnas.0907587106 Fig. S1. Primary structure alignment of SBT3 with C5 peptidase from Streptococcus pyogenes. The Matchmaker tool in UCSF Chimera (http:// www.cgl.ucsf.edu/chimera)
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature17991 Supplementary Discussion Structural comparison with E. coli EmrE The DMT superfamily includes a wide variety of transporters with 4-10 TM segments 1. Since the subfamilies of the
More informationStructure to Function. Molecular Bioinformatics, X3, 2006
Structure to Function Molecular Bioinformatics, X3, 2006 Structural GeNOMICS Structural Genomics project aims at determination of 3D structures of all proteins: - organize known proteins into families
More informationIntroduction to Structure Preparation and Visualization
Introduction to Structure Preparation and Visualization Created with: Release 2018-4 Prerequisites: Release 2018-2 or higher Access to the internet Categories: Molecular Visualization, Structure-Based
More informationQSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression
APPLICATION NOTE QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression GAINING EFFICIENCY IN QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS ErbB1 kinase is the cell-surface receptor
More informationIgnasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015
Ignasi Belda, PhD CEO HPC Advisory Council Spain Conference 2015 Business lines Molecular Modeling Services We carry out computational chemistry projects using our selfdeveloped and third party technologies
More informationImplementation of novel tools to facilitate fragment-based drug discovery by NMR:
Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Automated analysis of large sets of ligand-observed NMR binding data and 19 F methods Andreas Lingel Global Discovery Chemistry
More informationLecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability
Lecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability Part I. Review of forces Covalent bonds Non-covalent Interactions: Van der Waals Interactions
More informationPreparation and Characterization of Manganese (II) Complexes with Potential Therapeutic Application against α-synuclein Aggregation
Preparation and Characterization of Manganese (II) Complexes with Potential Therapeutic Application against α-synuclein Aggregation Kate Byrne BSc Medicinal Chemistry & Pharmaceutical Science Year 3 Project
More information